HANGZHOU RONGDA PHARM&CHEM CO., LTD

Keywords :

Entecavir API&Intermediates,Fulvestrant,Lapatinib

Dedicated in R&D, production, marketing of special API and intermediates, Rongda Pharm & Chem Co., Ltd has already established market to USA, EU region, ASEAN countries, etc with its experienced technocrats as core. Started business in the year of 2003, until now more than 200 initiative Rongda people, among which 115 people has got well colleage degree, grow with the company, who has well established organisational structure, including R&D, production, QA, etc. With the rapid development of the company, we have 2 exhisted plants spread in Anhui and Jiangxi province, and 1 more new plant construction in Jiangxi is on schedule for the future project. Our Jiangxi plant occupied 32, 000 m2;land area, which has about 5 workshops under operation.Tens of glass-lined or stainless reactors, whose volume is ranged from 200L to 3000L can be available, which can satify different reaction conditions.Moreover, our Anhui site currently is dedicated in production of some pharm intermediates.Concerning to QC test, we have equiped with different types of analytical intruments which can meet different test requirement. Our business has been separated into 2 parts, including marketing of our own API and intermediates as well as CRAMs (contract research and manufacturings). Great efforts has been made by Rongda people on the development of API, that we have focuse on the development anticancer products, and take cardiovascular & antidepressant series as our strategic developmet area. In addition, we have successfully expanded our business of Anastrozole, Lapatinib, Ibandronate sodium, Fulvestrant, Entecavir, Palonsetron HCl, Sorafenib, Erotinib, etc to some top 30 pharm giants. Moreover, with the clear trend of pharmaceutical manufacturing transfer from western countries to India and China, Rongda pharm strategically step into business of CRAMs, for which we have tens of experienced R&D scientists to support.